Qian Xie

机构：University of Leeds, Siemens (United States), Shenzhen Institutes of Advanced Technology, Shaanxi Normal University · ORCID：0000-0002-3755-8599

发表论文 53 篇 · 总被引 5808 次 · h-index 22

代表论文

• Identification of Andrographolide as a novel FABP4 inhibitor for osteoarthritis treatment (2023 · Phytomedicine · 被引 25)
• FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized mice (2025 · Nature Communications · 被引 24)
• Astragaloside IV as a novel CXCR4 antagonist alleviates osteoarthritis in the knee of monosodium iodoacetate-induced rats (2022 · Phytomedicine · 被引 22)
• Design, synthesis, and biological activity of a novel series of benzofuran derivatives against oestrogen receptor-dependent breast cancer cell lines (2020 · Bioorganic Chemistry · 被引 16)
• Identification of Influenza PAN Endonuclease Inhibitors via 3D-QSAR Modeling and Docking-Based Virtual Screening (2021 · Molecules · 被引 15)
• Synthesis, Characterization, and Biological Evaluation of Novel 7-Oxo-7H-thiazolo[3,2-b]-1,2,4-triazine-2-carboxylic Acid Derivatives (2020 · Molecules · 被引 13)